Deep Breeze launches radiation-free pulmonary imaging system in US
This article was originally published in Clinica
Executive Summary
Deep Breeze has launched its lung imaging system, VRIxp, in the US. The noninvasive radiation-free device employs vibration response imaging (VRI) technology, which uses lung sounds to create images. It records the sounds of the patient's breath, using sensors applied to the back, and an algorithm converts these data into images. It is designed for patients who arrive at the emergency department with dyspnoea, and can help diagnose several lung conditions including chronic obstructive pulmonary disease and asthma, as well as congestive heart failure. The FDA granted 510(k) clearance for the device in 2007 (www.clinica.co.uk, 24 August 2007), and Or-Akiva, Israel-based Deep Breeze CE marked it for sale in Europe in 2005 (www.clinica.co.uk, 7 October 2005).
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.